| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/ACS.JMEDCHEM.6B00228 |
| P698 | PubMed publication ID | 27031670 |
| P50 | author | Henriëtte M.G. Willems | Q52116793 |
| Alison J-A Woolford | Q57837773 | ||
| P2093 | author name string | James F Callahan | |
| Gordon Saxty | |||
| Rachel McMenamin | |||
| Thomas G Davies | |||
| Joseph E Coyle | |||
| Sharna J Rich | |||
| Tom D Heightman | |||
| Joseph P Foley | |||
| Caroline Richardson | |||
| Yolanda Sanchez | |||
| John G Yonchuk | |||
| Brian J Bolognese | |||
| Patricia L Podolin | |||
| David Norton | |||
| Joshua E Cottom | |||
| Hongxing Yan | |||
| Jeffrey K Kerns | |||
| Charlotte Griffiths-Jones | |||
| Gregory Logan | |||
| Heidi G Feldser | |||
| Jen-Pyng Kou | |||
| Keisha Hearn | |||
| William E Wixted | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | protein-protein interaction | Q896177 |
| P304 | page(s) | 3991-4006 | |
| P577 | publication date | 2016-04-28 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery | |
| P478 | volume | 59 |
| Q38648131 | A Computational Investigation of Small-Molecule Engagement of Hot Spots at Protein-Protein Interaction Interfaces. |
| Q95298689 | A hydrogen peroxide responsive prodrug of Keap1-Nrf2 inhibitor for improving oral absorption and selective activation in inflammatory conditions |
| Q42283243 | Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer |
| Q92511933 | Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development |
| Q90172097 | An open-source drug discovery platform enables ultra-large virtual screens |
| Q91678049 | CPUY192018, a potent inhibitor of the Keap1-Nrf2 protein-protein interaction, alleviates renal inflammation in mice by restricting oxidative stress and NF-κB activation |
| Q90476028 | Chemical Space Overlap with Critical Protein-Protein Interface Residues in Commercial and Specialized Small-Molecule Libraries |
| Q57069735 | Design and development of Nrf2 modulators for cancer chemoprevention and therapy: a review |
| Q90691323 | Development of a Cell-Permeable Cyclic Peptidyl Inhibitor against the Keap1-Nrf2 Interaction |
| Q40060254 | Differential regulation of innate immune cytokine production through pharmacological activation of Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) in burn patient immune cells and monocytes. |
| Q46470953 | Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells |
| Q90061778 | Emerging Screening Approaches in the Development of Nrf2-Keap1 Protein-Protein Interaction Inhibitors |
| Q41560359 | Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition |
| Q90302606 | Fabrication and characterization of solid lipid nano-formulation of astraxanthin against DMBA-induced breast cancer via Nrf-2-Keap1 and NF-kB and mTOR/Maf-1/PTEN pathway |
| Q27720581 | Fragment Screening of RORγt Using Cocktail Crystallography: Identification of Simultaneous Binding of Multiple Fragments |
| Q42217007 | Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation. |
| Q41512122 | Hot-spot identification on a broad class of proteins and RNA suggest unifying principles of molecular recognition. |
| Q52564221 | Identification of a novel small-molecule Keap1-Nrf2 PPI inhibitor with cytoprotective effects on LPS-induced cardiomyopathy. |
| Q41858529 | Identification of novel Nrf2 activators from Cinnamomum chartophyllum H.W. Li and their potential application of preventing oxidative insults in human lung epithelial cells |
| Q64892205 | Identification of novel indole derivatives acting as inhibitors of the Keap1-Nrf2 interaction. |
| Q47726693 | Mimicking Intermolecular Interactions of Tight Protein-Protein Complexes for Small-Molecule Antagonists. |
| Q89174376 | Modified Peptide Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction Incorporating Unnatural Amino Acids |
| Q54254841 | Opsonic Phagocytosis in Chronic Obstructive Pulmonary Disease is Enhanced by Nrf2 Agonists. |
| Q41064004 | Polar Recognition Group Study of Keap1-Nrf2 Protein-Protein Interaction Inhibitors |
| Q97882881 | Potent Natural Antioxidant Carveol Attenuates MCAO-Stress Induced Oxidative, Neurodegeneration by Regulating the Nrf-2 Pathway |
| Q99616637 | Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials |
| Q39270529 | Recent progress in the development of small molecule Nrf2 modulators: a patent review (2012-2016). |
| Q47903962 | Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress |
| Q91013930 | Targeted protein degradation: expanding the toolbox |
| Q98224507 | Targeting the Heme Oxygenase 1/Carbon Monoxide Pathway to Resolve Lung Hyper-Inflammation and Restore a Regulated Immune Response in Cystic Fibrosis |
| Q38889475 | The role of modulation of antioxidant enzyme systems in the treatment of neurodegenerative diseases |
| Q90893987 | Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases |
| Q36078186 | Twenty years on: the impact of fragments on drug discovery |
| Q64255858 | Unsupervised identification of disease states from high-dimensional physiological and histopathological profiles |
| Q47291150 | WD40 repeat domain proteins: a novel target class? |
| Q29248295 | Zinc oxide nanoparticles exhibit cytotoxicity and genotoxicity through oxidative stress responses in human lung fibroblasts and Drosophila melanogaster |
Search more.